Dr Reddy’s Laboratories: Global pharmaceutical company, India

  Quick Links
   Company News Coverage
   Sustainability Report
   NCE Pipeline
   Our Values
 
Get it here
             first-hand
  Press Releases

Subscriptions: Want to stay updated? Click here to subscribe to our press releases
Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Feb  | Jan
 
Dr Reddy's to discuss Omeprazole developments in Conference Call slated for 22 November, 3PM IST
November 21, 2001
Dr Reddy's Laboratories Limited Announces Agreement For Utilizing Incyte LifeSeq Gold Online
November 20, 2001
Dr Reddy's loses eligibility for 180-day exclusivity for Omeprazole 40 mg capsules
November 17, 2001
World Diabetes Day: Livizi's endeavor to make a difference
November 13, 2001
Dr Reddy's launches Gaity; expects to consolidate position in the quinolones market
November 13, 2001
Reddy US to present preclinical research findings at The American Heart Association Scientific Sessions 2001
November 9, 2001
Novo Nordisk commences Phase 3 clinical trials of DRF 2725 (NN622)
November 6, 2001
Dr Reddy's launches Hyalosyn for the treatment of Osteoarthritis
November 5, 2001
Dr Reddy's Laboratories receives US FDA final approval for Ibuprofen tablets  
November 1, 2001

The information contained in the releases was current on the date they were issued and will become or may have become outdated over time. Dr. Reddy's does not assume any responsibility for updating
information in the releases.

  Triple Bottom Line
  Download Brochures
  Key Milestones
   
Designed by
© 2001 - 2008 Dr. Reddy's Laboratories Ltd. All rights reserved
Site best viewed at 800x600 resolution